This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre Medicament. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Michel Favaron: Innovator in Polysaccharide Composition
Introduction
Michel Favaron is a notable inventor based in Saint-Julien-en-Genevois, France. He has made significant contributions to the field of polysaccharide compositions, particularly in the area of imaging technologies. His work has led to the development of innovative solutions that have potential applications in various scientific fields.
Latest Patents
Michel Favaron holds a patent for a "Partially delipidated D25 polysaccharide composition for imaging." This invention relates to a D25 polysaccharide compound whose lipid has been partially removed. The compound exists in aqueous solution in monomeric form, with at least 85% by weight, preferably 90%. The polysaccharide compound, which has a molecular weight of 30 kD, is extracted from the membrane proteoglycan of the bacterium Klebsiella pneumoniae. Notably, the amount of palmitic fatty acids bound to it in esterified form does not exceed 0.01% by weight, and the amount associated with it in free form does not exceed 0.1% by weight.
Career Highlights
Michel Favaron is associated with Pierre Fabre Medicament, where he has been able to apply his expertise in polysaccharide research. His innovative work has contributed to the advancement of medical and imaging technologies.
Collaborations
Some of his notable coworkers include Lucien Dussourd d'Hinterland and Gerard Normier. Their collaborative efforts have further enhanced the research and development of polysaccharide applications.
Conclusion
Michel Favaron's contributions to the field of polysaccharide compositions demonstrate his innovative spirit and dedication to advancing scientific knowledge. His patent reflects a significant step forward in imaging technologies, showcasing the potential of partially delipidated polysaccharides.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
